Etienne Gimenez

Etienne Gimenez serves as CEO at Laboratoires Crinex. Laboratoires Crinex operates in the pharmaceuticals sector with approximately 27.0 employees. The company is headquartered in Paris, Ile-de-France.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 4,101 executive contacts are available in Ile-de-France.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 PrestaShop reCAPTCHA Mobile Friendly Google Tag Manager Apache Google Analytics Google Font API

dentaire pediatrie hygiene buccodentaire brossettes interdentaires vitamine d pharmaceutical manufacturing dental hygiene dietary supplements oral care children vitamins intestinal balance whitening toothpaste bad breath treatment gum care interdental brushes fluoride toothpaste family wellness pregnant women vitamins probiotic supplements sensitive teeth travel dental kit breath freshening microbiome support supplementation natural ingredients healthy teeth healthy gums nutritional balance health education vitamin d3 probiotics for children antibacterial agents oral health chronic pain management baby nutrition nutrition advice healthy lifestyle holistic health dental care routine oral pathology natural remedies anti-inflammatory growth support immune support healthy diet family nutrition therapeutic diet healthy habits vitamins for pregnant women pain relief child development nutrient-rich infant dietary needs daily vitamins pharmaceuticals medical health wellness & fitness

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Etienne Gimenez in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Laboratoires Crinex.

Etienne Gimenez's Position in the MessageCEO Database

• •Etienne Gimenez is 1 of 1 verified executive contact we track at Laboratoires Crinex.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •4,045 verified executive contacts in Ile-de-France are in the database.
• •12 verified contacts work at pharmaceuticals companies in the 27.0 employee range (same size as Laboratoires Crinex).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Etienne Gimenez directly?

Etienne Gimenez's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Laboratoires Crinex. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Etienne Gimenez work for?

Etienne Gimenez is CEO at Laboratoires Crinex, a company in the pharmaceuticals sector with 27.0 employees. The company is based in Paris, Ile-de-France.

Can I pitch or sell to Etienne Gimenez?

As CEO at Laboratoires Crinex, Etienne Gimenez is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Etienne Gimenez directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Etienne Gimenez in?

Etienne Gimenez works in the pharmaceuticals industry as CEO at Laboratoires Crinex. MessageCEO provides verified contact information for executives across all major industries.

Is Etienne Gimenez's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Etienne Gimenez's profile is kept up-to-date with the latest available information.

Last updated: July 18, 2026